Status:

COMPLETED

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

Lead Sponsor:

Peter MacCallum Cancer Centre, Australia

Collaborating Sponsors:

M.D. Anderson Cancer Center

Melbourne Health

Conditions:

Cancer, Breast

Cancer Colorectal

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

A multicentre, prospective randomized, active-controlled feasibility trial of volatile-based anaesthesia vs. propofol-based total intravenous anaesthesia to investigate the impact of anaesthesia on lo...

Detailed Description

This study aims to assess the feasibility of conducting a phase IV, multi-centre, single-blinded, randomized control trial (VAPOR-C (Main)). Primary aims To measure the ability to recruit eligible pa...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Male or female
  • Age 18-80 years
  • Elective surgery
  • Major cancer surgery expecting to last two or more hours, for:
  • Breast (mastectomy or segmentectomy plus sentinel node dissection)
  • Colorectal
  • Lung
  • Prostate
  • Melanoma (excision of melanoma plus lymph node dissection AND/OR skin flap construction
  • Other major cancer surgeries (e.g. oesophagectomy, head and neck cancer, etc.)
  • Exclusion Criteria
  • Palliative surgery for end-stage disease with no curative intent
  • Emergency surgery
  • Extensive comorbid disease, i.e. American Society of Anesthesiologists (ASA) Score \> 4
  • Age \<18 or \>80 years old
  • Refusal or inability to provide valid informed consent
  • Risk of severe postoperative nausea and vomiting (PONV risk score \>3)
  • Previous allergy or contraindication to either anaesthetic medication
  • Indication for gas induction of anaesthesia
  • Currently enrolled in another clinical trial unless agreed by the coordinating principal investigator and site principal investigator that co-enrolment can occur.

Exclusion

    Key Trial Info

    Start Date :

    August 27 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 30 2020

    Estimated Enrollment :

    169 Patients enrolled

    Trial Details

    Trial ID

    NCT04074460

    Start Date

    August 27 2017

    End Date

    June 30 2020

    Last Update

    June 9 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Peter MacCallum Cancer Centre

    Melbourne, Australia